Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...

In his letter, Drummond told Walters and Education Department officials to act quickly to make sure public school students have access to the inhalers. "Waiting more than a year to ask for guidance, ...

OKLAHOMA CITY (KFOR) — Oklahoma Attorney General Gentner Drummond sent State Superintendent Walters a scathing legal letter Wednesday, dressing down Walters for the Oklahoma State Department of ...

Oklahoma Attorney General Gentner Drummond criticized state schools Superintendent Ryan Walters and the Oklahoma State Department of Education on Wednesday for delaying the purchase of emergency ...

Inhalers and nebulizers are devices that deliver medicine directly into the lungs. The difference between the two devices is in the way they deliver the medication. An inhaler relies on pressure, ...

Inhaled anaesthetic agents are estimated to account for up to 3% of total national healthcare greenhouse gas emissions in high income countries, and between 0.01% and 0.1% of greenhouse gas emissions ...

Tea tree oil is promoted as a treatment for some skin conditions and for its antimicrobial properties. However, it is toxic when taken orally and may cause other unwanted side effects. Share on ...

A salt pipe is an inhaler containing salt particles. Advocates of salt pipes suggest they help with many health conditions, including asthma, but scientific support is limited. Salt therapy ...

Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs. The lungs are one of the most complicated organs in the body. Therefore, there are several ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.